Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3100
-0.0060 (-1.90%)
Sep 23, 2026, 9:01 AM CET
Biovica International AB Income Statement
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Operating Revenue | 14.83 | 13.38 | 8.62 | 7.29 | 3.38 | 2.05 |
Other Revenue | 0.11 | 0.11 | 0.03 | 0.01 | 0.26 | 0.06 |
| 14.93 | 13.49 | 8.65 | 7.3 | 3.64 | 2.11 | |
Revenue Growth | 56.73% | 55.93% | 18.55% | 100.52% | 72.75% | -46.28% |
Cost of Revenue | 0.47 | 0.04 | 0.54 | 0.41 | 0.34 | 0.37 |
Gross Profit | 14.47 | 13.44 | 8.11 | 6.88 | 3.3 | 1.74 |
Selling, General & Admin | 77.85 | 75.09 | 85.63 | 123.52 | 106.69 | 59.35 |
Other Operating Expenses | 0.34 | 0.7 | 1.78 | 1.56 | -0.68 | -3.83 |
Operating Expenses | 86.01 | 84.08 | 96.25 | 134.51 | 114.22 | 61.95 |
Operating Income | -71.54 | -70.64 | -88.14 | -127.63 | -110.92 | -60.22 |
Interest Expense | -0.29 | -0.4 | -0.22 | -0.29 | -0.28 | -0.08 |
Interest & Investment Income | 0.48 | 0.74 | 1 | 1.16 | 0.27 | - |
Currency Exchange Gain (Loss) | 0.79 | 0.79 | 1.38 | 2.63 | 0.17 | 0.25 |
Other Non Operating Income (Expenses) | -0.1 | 0 | -0 | - | 0 | - |
EBT Excluding Unusual Items | -70.66 | -69.51 | -85.98 | -124.14 | -110.76 | -60.04 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.08 | 0.05 |
Pretax Income | -70.66 | -69.51 | -85.98 | -124.14 | -110.68 | -59.99 |
Income Tax Expense | 1.57 | 0.35 | 1.64 | 0.69 | -0.19 | 0.01 |
Net Income | -72.23 | -69.86 | -87.62 | -124.82 | -110.49 | -60 |
Net Income to Common | -72.23 | -69.86 | -87.62 | -124.82 | -110.49 | -60 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 283 | 235 | 93 | 58 | 35 | 28 |
Shares Outstanding (Diluted) | 283 | 235 | 93 | 58 | 35 | 28 |
Shares Change | 195.13% | 153.64% | 58.49% | 67.70% | 22.40% | 0.17% |
EPS (Basic) | -0.25 | -0.30 | -0.95 | -2.14 | -3.17 | -2.11 |
EPS (Diluted) | -0.26 | -0.30 | -0.95 | -2.14 | -3.17 | -2.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Free Cash Flow | -64.04 | -63.28 | -85.65 | -114.72 | -95.85 | -52.53 |
Free Cash Flow Per Share | -0.23 | -0.27 | -0.93 | -1.96 | -2.75 | -1.85 |
Gross Margin | 96.87% | 99.68% | 93.81% | 94.34% | 90.65% | 82.38% |
Operating Margin | -479.08% | -523.85% | -1019.20% | -1749.57% | -3049.04% | -2859.35% |
Profit Margin | -483.70% | -518.06% | -1013.23% | -1711.08% | -3037.16% | -2849.14% |
Free Cash Flow Margin | -428.83% | -469.27% | -990.45% | -1572.60% | -2634.58% | -2494.40% |
EBITDA | -70.93 | -69.55 | -87.06 | -126.55 | -109.71 | -59.01 |
D&A For EBITDA | 0.62 | 1.09 | 1.08 | 1.08 | 1.22 | 1.21 |
EBIT | -71.54 | -70.64 | -88.14 | -127.63 | -110.92 | -60.22 |
Revenue as Reported | 15.35 | 14.01 | 10.96 | 8.3 | 5.7 | 6.3 |